Health for all: It is expected that the net profit attributable to the parent company will be between a loss of 46 million yuan to 55 million yuan in the first half of the year.

Ji Min Health announced on July 11th that it is expected to have a net loss attributable to the parent company in the first half of 2025 ranging from -55 million to -46 million yuan, compared to a profit of 25.445 million yuan in the same period last year. The company stated that the main reason for the expected loss in performance is the impact of U.S. tariffs and the "He Qinghong private seal incident", resulting in a decline in sales revenue of the company's safety injectors and pre-filled catheter flushers. Additionally, based on prudence principle, the company had to make further provisions for impairment of inventory of pre-filled catheter flushers and safety injectors.